Hvidovre, Denmark

Carsten Overballe-Petersen

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Xellia Pharmaceuticals Aps. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carsten Overballe-Petersen. Retrieved from https://idiyas.com/inventor/carsten-overballe-petersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carsten Overballe-Petersen: Innovator in Lipopeptide Purification

Introduction

Carsten Overballe-Petersen is a notable inventor based in Hvidovre, Denmark. He has made significant contributions to the field of pharmaceutical purification processes, particularly in lipopeptides.

Latest Patents

Overballe-Petersen holds a patent titled "Process for Purifying Lipopeptides." This innovative process centers around an improved method for purifying daptomycin, enhancing the efficiency and effectiveness of the purification stage in pharmaceutical manufacturing.

Career Highlights

Carsten is associated with Xellia Pharmaceuticals Aps, a reputable company known for its development of high-quality antibiotics and other critical medications. His work at Xellia highlights his dedication to advancing pharmaceutical technologies.

Collaborations

Throughout his career, Carsten has collaborated with skilled professionals such as Martin Mansson and Eli Karin Dale. These partnerships have likely contributed to the successful development and implementation of his patented processes.

Conclusion

Carsten Overballe-Petersen's contributions to the field of lipopeptide purification represent a significant advancement in pharmaceutical sciences. His dedication to innovation and collaboration continues to push the boundaries of what is possible in drug manufacturing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…